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Mutations in proteins allow functional innovation, but can be critically
destabilizing. Recent work shows how chaperonins can rescue innovative
mutants, with implications for protein engineering and adaptive evolution.D. Allan Drummond
Like hikers on a cliff edge, proteins tend
to be one step away from a disastrous
fall. Over evolutionary time, proteins
hike in sequence space [1], with each
step corresponding to a sequence
change, most often a single amino-acid
substitution. Each step offers the
opportunity, however unlikely, to
acquire improved or novel activity, yet
also carries the risk, often quite likely,
of becoming unstable (Figure 1A),
leading to misfolding and degradation.
For protein engineers looking to
explore new functions, and perhaps
for organisms faced with a new
environmental challenge, the most
useful substitutions may at the same
time be the most disruptive to protein
stability [2,3]. Innovation, in short, is
costly. Recent work [4] suggests that
this cost of innovation can be mitigated
by helper proteins called chaperonins
which help some of their protein clients
to accumulate more, and sometimes
more useful, substitutions than they
could in the absence of folding
assistance.
Stability to Folding to Activity
Most proteins fold with a net stability
equivalent to that of a handful of
hydrogen bonds or, importantly, to the
effect of a single destabilizing amino
acid substitution. Critically destabilized
proteins cannot maintain the folded
state that confers their biological
activity, and tend to aggregate, often
observed macroscopically as a sharp
decrease in solubility. In a rare study
where protein folding and functionwere measured independently for
a large number of enzymes bearing
random mutations, almost all folded
proteins at least retained parental
function [2]. Amino acid changes that
preserve stable folding represent
opportunities for functional innovation,
and indeed, in the same study, a
more-stable enzyme variant acquired
novel functions at a far higher rate
than its less-stable counterpart [2].
Conversely, when directed evolution of
a fatty-acid hydroxylase toward activity
on short-chain alkanes stalled, it was
because the innovative mutations had
destabilized the enzyme such that few,
if any, additional mutations could be
tolerated [5]. Stabilizing the enzyme,
however, enabled the mutational
march toward new substrates to
resume [5]. Another way to accelerate
acquisition of new protein functions
would be to provide a system to buffer
the effects of destabilizing mutations
[2], and chaperones offer a perfect
example of such a system.
The bacterial chaperonins GroEL
and GroES form a cavity in which
amino-acid chains can attempt to
fold while protected from the crowded
intracellular milieu. About 10% of
soluble Escherichia coli proteins are
clients of GroEL/S [6], which are known
to suppress a wide range of mutations
[7]. By performing mutation-
accumulation experiments on four
soluble enzymes under conditions
where GroEL/S were alternately
overexpressed or expressed normally,
Tokuriki and Tawfik [4] demonstrated
that a larger fraction of mutant proteins
retained activity in the presence of highchaperonin levels than at normal
levels of expression. Many of the
chaperonin-compensated proteins
had folding defects appearing as
decreased solubility in the absence
of GroEL/S. These findings suggest
that the chaperonins have the
potential to promote accumulation
of genetic diversity.
How GroEL/S rescues mutant
proteins with folding defects has been
demonstrated in a series of studies by
Teschke, King and colleagues [8–11].
Using a set of temperature-sensitive
folding (tsf) mutants of the
bacteriophage P22 coat protein, a
model substrate which is amenable to
detailed folding studies and has a clear
functional assay, they have shown that
tsf substitutions that are intolerable in
the absence of GroEL/S chaperonins
can be rescued in the presence of the
chaperonins [8]. Such rescue occurs
through direct interaction between the
chaperonins and the destabilized
protein, preventing aggregation
monitored by decreased solubility [9].
Moreover, suppressor mutations
in tsf mutants facilitate the
chaperonin2substrate interaction
[10], and chaperonins act to bias
polypeptide flux away from
aggregation of a folding intermediate
and toward folding and assembly
[10,11]. Interestingly, wild-type P22
coat protein is not a GroEL/S client,
whereas its tsf mutants are [8,9].
Rescuing Innovative Mutants
Although the P22 coat-protein work
anticipates many more recent results,
this system lacks a screen for
functional diversification, leaving the
possible functional effects of the
additional mutations rescued by
GroEL/S unaddressed. By contrast,
enzymes have obvious diversification
potential due to wide-ranging activities
on different substrates. Focusing
Dispatch
R741on a variant of the enzyme
phosphotriesterase from
Pseudomonas sp., Tokuriki and
Tawfik [4] used two rounds of
mutagenesis and screening in order
to select phosphotriesterase mutants
with improved hydrolysis activity
on the chromogenic ester
2-naphthylhexanoate (2-NPH), a
poor substrate for the starting enzyme.
Without GroEL/S overexpression,
the mutant libraries yielded an up to
3.4-fold improvement in enzymatic
activity with up to a 4.2-fold higher
substrate selectivity. With GroEL/S
overexpression, however, mutants with
an up to 44-fold higher esterase activity
and a 54-fold higher selectivity were
isolated. Importantly, a first-round
mutation accumulated in the presence
of GroEL/S overexpression conferred
a nearly 12-fold improvement in
esterase activity but also compromised
folding, such that the amount of soluble













Figure 1. Helping to stabilize innovative
mutations.
(A) Wild-type proteins (blue) are typically
marginally stable, and mutants (red), which
have a chance to access novel activities,
tend to be destabilized, often leading to
loss of fold and function (right). (B) Pre-stabi-
lization of a wild-type enzyme makes more
destabilizing mutations tolerable, allowing
access to novel activities. (C) Chaperonins
help destabilized mutants to fold, allowing
access to novel activities.absence of chaperonin
overexpression. These results identify
chaperonins as a buffer for
destabilizing yet functionally innovative
mutations [2], and reflect the simple
idea that the major predictor of
improved function in a large collection
of mutant proteins is simply the
number of folded polypeptides
with unique sequences in that
collection [12].
The notion that chaperones could
buffer evolutionarily important genetic
variation, conferring ‘phenotypic
capacitance’ in the sense of producing
a consistent phenotypic output given
variable genetic inputs, was introduced
by Rutherford and Lindquist [13] in a
study of the effects of the chaperone
Hsp90 on Drosophila melanogaster
morphology. In those experiments,
startling lineage-specific
morphological variation arose upon
inhibition of Hsp90, whose clients
include many transcription factors.
Similar results were obtained in
Arabidopsis thaliana [14], where alleles
with Hsp90-dependent phenotypes
are common [15]. The evolutionary
argument holds that the genotypic
and resulting phenotypic variation
suppressed by the chaperone could
be adaptive in some environments.
The chaperone’s activity would thus
allow a population to maintain a
hidden portfolio of ‘genetic wagers’
which could enable faster adaptation
upon environmental change — so long
as such changes transiently suppress
the chaperone’s activity, revealing
cryptic variation and, in a sense,
placing previously hidden ‘wagers’
on the table.
The new GroEL/S overexpression
study provides a molecular counterpart
to the idea of morphological ‘hopeful
monsters’ — a set of mutant proteins
bearing novel mutations and, in at least
one case, enhanced enzymatic
activities (hope) along with structural
defects (monstrosity) which require
chaperonin assistance. Hsp90 workers
tend to assert that the stress of a
changing environment will overload
or otherwise reduce the efficacy of
the chaperone [15], revealing adaptive
variation, whereas Tokuriki and
Tawfik [4] note that stress induces
chaperone expression, allowing
mutant proteins to survive and
contribute adaptively with higher
probability [4]. Future work must
reconcile these plausible but
opposing hypotheses.The optimal method for isolating
improved proteins — both during
protein evolution and during directed
protein design — remains an active area
of study. Chaperonin overexpression
[4] and pre-stabilization of proteins [2]
provide alternative, and compatible,
strategies for improving the yield of
novel enzymes (Figure 1). Notably,
Tokuriki and Tawfik [4] report that
in vitro evolution of the model proteins
(and known GroEL/S clients) GFP and
b-lactamase did not support the trends
they observed for the four enzymes
they discuss in detail. How chaperonin
activity influences organismal evolution
remains even more murky. But the
chaperonin-facilitated molecular
innovation detailed in recent studies
provides tantalizing fodder for an
experimental demonstration of
phenotypic capacitance — the
emergence of chaperone-buffered
phenotypic novelty — in laboratory
evolution.
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